Reply to Hall J: "Use of the Fluocinolone Acetonide Intravitreal Implant for the Treatment of Noninfectious Posterior Uveitis: 3-Year Results of a Randomized Clinical Trial in a Predominantly Asian Population" : Virender S. Sangwan, P. Andrew Pearson, Hemanth Paul, Timothy L. Comstock

Affiliations

Baldo Scassellati Sforzolini. Ophthalmol Ther. 2015 Jun.

. 2015 Jun;4(1):67-8.

doi: 10.1007/s40123-015-0030-6. Epub 2015 Mar 21.

¹ Eye Care, Valeant Pharmaceuticals, Bridgewater, NJ, USA, Baldo.Sforzolini@bausch.com.

No abstract available

References

1. Sangwan VS, Pearson PA, Paul H, Comstock TL. Use of the fluocinolone acetonide intravitreal implant for the treatment of noninfectious posterior uveitis: 3-year results of a randomized clinical trial in a predominantly Asian population. Opthalmol Ther. doi:10.1007/s40123-014-0027-6. - PMC - PubMed
1. Hall J. Comment on: Use of the fluocinolone acetonide intravitreal implant for the treatment of noninfectious posterior uveitis: 3-year results of a randomized clinical trial in a predominantly Asian population. Ophthalmol Ther. 2014. doi:10.1007/s40123-015-0029-z. - PMC - PubMed
1. Pearson PA, Comstock TL, Ip M, et al. Fluocinolone acetonide intravitreal implant for diabetic macular edema: a 3-year multicenter, randomized, controlled clinical trial. Ophthalmology. 2011;118(8):1580–1587. doi: 10.1016/j.ophtha.2011.02.048. - DOI - PubMed
1. Ramchandran RS, Fekrat S, Stinnett SS, Jaffe GJ. Fluocinolone acetonide sustained drug delivery device for chronic central retinal vein occlusion: 12-month results. Am J Ophthalmol. 2008;146:285–291. doi: 10.1016/j.ajo.2008.03.025. - DOI - PubMed
1. Jain N, Stinnett SS, Jaffe GJ. Prospective study of a fluocinolone acetonide implant for chronic macular edema from central retinal vein occlusion: thirty-six-month results. Ophthalmology. 2012;119:132–137. doi: 10.1016/j.ophtha.2011.06.019. - DOI - PubMed